Novel truncating germline variant reinforces TINF2 as a susceptibility gene for familial non-medullary thyroid cancer

被引:0
|
作者
Oriola, Josep [1 ,2 ]
Diez, Orland [3 ]
Mora, Mireia [4 ,5 ]
Halperin, Irene [6 ]
Martinez, Sandra [7 ]
Masas, Miriam [8 ]
Tenes, Anna [8 ]
Bernal, Anna [9 ]
Duran, Rafael [10 ]
Orois, Aida [11 ]
机构
[1] Hosp Clin Barcelona, Biochem & Mol Genet Dept, Barcelona 08036, Spain
[2] Univ Barcelona, Fac Med & Ciencies Salut, Biomed, Barcelona, Spain
[3] Vall Hebron Inst dOncol, Area Clin & Mol Genet, Canc Genet Grp, Barcelona, Spain
[4] Hosp Clin Barcelona, Inst Invest Biomed August Pi i Sunyer IDIBAPS, Endocrinol & Nutr Dept, Barcelona, Spain
[5] Univ Barcelona, Fac Med & Ciencies Salut, Barcelona, Spain
[6] Hosp Clin Barcelona, Endocrinol Dept, ICMDM, Barcelona, Spain
[7] Hosp Gen Elda, FED Endocrinol & Nutr, Elda, Spain
[8] Vall dHebron Univ Hosp, Clin & Mol Genet Area, Barcelona, Spain
[9] Hosp Clin Barcelona, Biochem & Mol Genet, Barcelona, Spain
[10] Hosp Gen Elda, Serv Patol, Elda, Spain
[11] Hosp Clin Barcelona, Endocrinol, ICMDM, Barcelona, Spain
关键词
Endocrine Gland Neoplasms; Frameshift Mutation; Genetics; Medical; Genetic Testing; Germ-Line Mutation; DYSKERATOSIS-CONGENITA; MUTATION;
D O I
10.1136/jmg-2024-110185
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background It has long been observed that there are families in which non-medullary thyroid cancer (NMTC) occurs, but few syndromes and genes have been described to date. Proteins in the shelterin complex have been implied in cancer. Here, we have studied shelterin genes in families affected by NMTC (FNMTC). Methods We performed whole-exome sequencing (WES) in 10 affected individuals from four families with at least three affected members. Polymerase chain reaction (PCR) and Sanger sequencing were performed to search for variants in the TINF2 gene in 40 FNMTC families. TINF2 transcripts and loss of heterozygosity (LOH) were studied in several affected patients of one family. Results We found the c.507G>T variant in heterozygosis in the TINF2 gene in one family, co-segregating in all five affected members. This variant affects the normal splicing. LOH was not observed. Conclusions Our results reinforce the TINF2 gene as a susceptibility cause of FNMTC suggesting the importance of location of frameshift variants in TINF2. According to our data and previous literature, TINF2 pathogenic variants appear to be a significant risk factor for the development of NMTC and/or melanoma.
引用
收藏
页码:939 / 942
页数:4
相关论文
共 50 条
  • [41] Lack of Mutations in POT1 Gene in Selected Families with Familial Non-Medullary Thyroid Cancer
    Orois, Aida
    Badenas, Celia
    Reverter, Jordi L.
    Lopez, Veronica
    Potrony, Miriam
    Mora, Mireia
    Halperin, Irene
    Oriola, Josep
    HORMONES & CANCER, 2020, 11 (02): : 111 - 116
  • [42] Should Total Thyroidectomy Be Recommended for Patients with Familial Non-medullary Thyroid Cancer?
    Yon Seon Kim
    Minjung Seo
    Seol Hoon Park
    So Yeon Ju
    Eun Sook Kim
    World Journal of Surgery, 2020, 44 : 3022 - 3027
  • [43] Risk of Second Malignant Neoplasm in Familial Non-Medullary Thyroid Cancer Patients
    Capezzone, Marco
    Sagnella, Alfonso
    Cantara, Silvia
    Fralassi, Noemi
    Maino, Fabio
    Forleo, Raffaella
    Brilli, Lucia
    Pilli, Tania
    Cartocci, Alessandra
    Castagna, Maria Grazia
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [44] Should Total Thyroidectomy Be Recommended for Patients with Familial Non-medullary Thyroid Cancer?
    Kim, Yon Seon
    Seo, Minjung
    Park, Seol Hoon
    Ju, So Yeon
    Kim, Eun Sook
    WORLD JOURNAL OF SURGERY, 2020, 44 (09) : 3022 - 3027
  • [45] Current Knowledge of Germline Genetic Risk Factors for the Development of Non-Medullary Thyroid Cancer
    Hincza, Kinga
    Kowalik, Artur
    Kowalska, Aldona
    GENES, 2019, 10 (07)
  • [46] Identification of NID1 as a novel candidate susceptibility gene for familial non-medullary thyroid carcinoma using whole-exome sequencing
    Barbalho de Mello, Luis Eduardo
    Ribeiro Carneiro, Thaise Nayane
    Araujo, Aline Neves
    Alves, Camila Xavier
    Favoretto Galante, Pedro Alexandre
    Buzatto, Vanessa Candiotti
    de Almeida, Maria das Gracas
    Vermeulen-Serpa, Karina Marques
    de Lima Vale, Sancha Helena
    de Pinto Paiva, Fernando Jose
    Brandao-Neto, Jose
    Cerutti, Janete Maria
    ENDOCRINE CONNECTIONS, 2022, 11 (01)
  • [47] NOP53 as A Candidate Modifier Locus for Familial Non-Medullary Thyroid Cancer
    Orois, Aida
    Gara, Sudheer K.
    Mora, Mireia
    Halperin, Irene
    Martinez, Sandra
    Alfayate, Rocio
    Kebebew, Electron
    Oriola, Josep
    GENES, 2019, 10 (11)
  • [48] Is familial non-medullary thyroid carcinoma more aggressive than sporadic thyroid cancer? A multicenter series
    Alsanea, O
    Wada, N
    Ain, K
    Wong, M
    Taylor, K
    Ituarte, PHG
    Treseler, PA
    Weier, HU
    Freimer, N
    Siperstein, AE
    Duh, QY
    Takami, H
    Clark, OH
    SURGERY, 2000, 128 (06) : 1043 - 1050
  • [49] Risk of non-medullary thyroid cancer influenced by polymorphic variation in the thyroglobulin gene
    Matakidou, A
    Hamel, N
    Popat, S
    Henderson, K
    Kantemiroff, T
    Harmer, C
    Clarke, SEM
    Houlston, RS
    Foulkes, WD
    CARCINOGENESIS, 2004, 25 (03) : 369 - 373
  • [50] A novel germline variant inRETgene resulting in an additional cysteine in a family with familial medullary thyroid carcinoma
    Oriola, Josep
    Sanchez, Aurora
    Paniello, Blanca
    de la Bellacasa, Jordi Puig
    Biarnes, Josefina
    FAMILIAL CANCER, 2021, 20 (03) : 253 - 256